Beauty Health (SKIN) withholds 26,776 CFO shares for taxes

Rhea-AI Filing Summary

Beauty Health Co Chief Financial Officer Michael P. Monahan had 26,776 shares of Class A Common Stock withheld by the company to cover tax obligations on vested restricted stock units. The shares were valued at $0.92 per share for this tax-withholding transaction.

After this non-market disposition, which the company states does not represent a sale, Monahan directly holds 1,987,637 shares of Beauty Health Co Class A Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MONAHAN MICHAEL P.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Class A Common Stock	26,776	$0.92	$25K

Holdings After Transaction: Class A Common Stock — 1,987,637 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 26,776 shares Withholding price per share: $0.92 per share Shares held after transaction: 1,987,637 shares

3 metrics

Shares withheld for taxes 26,776 shares Tax withholding on RSU vesting for CFO

Withholding price per share $0.92 per share Valuation used for tax-withholding disposition

Shares held after transaction 1,987,637 shares CFO’s direct Class A Common Stock holdings post-transaction

Key Terms

restricted stock units, tax withholding requirements, Class A Common Stock, Form 4

4 terms

restricted stock units financial

"vesting of restricted stock units and does not represent a sale"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding requirements financial

"withheld by the issuer to satisfy tax withholding requirements on vesting"

Class A Common Stock financial

"security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MONAHAN MICHAEL P.

(Last) (First) (Middle)

C/O THE BEAUTY HEALTH COMPANY

3600 E. BURNETT STREET

(Street)

LONG BEACH CALIFORNIA 90815

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/09/2026		F(1)		26,776	D	$0.92	1,987,637	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

Remarks:

	/s/ Paul Bokota, Attorney-in-fact for Michael Monahan	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Beauty Health (SKIN) CFO Michael Monahan report in this Form 4?

Beauty Health CFO Michael Monahan reported a tax-related share disposition. The company withheld 26,776 shares of Class A Common Stock to satisfy tax obligations on vesting restricted stock units, and this withholding is explicitly described as not representing a market sale.

How many Beauty Health (SKIN) shares were withheld for the CFO’s taxes?

A total of 26,776 Class A Common Stock shares were withheld. These shares were used to satisfy tax withholding requirements arising from the vesting of restricted stock units, rather than being sold on the open market or in any other trading transaction.

At what price per share were the withheld Beauty Health (SKIN) shares valued?

The withheld shares were valued at $0.92 per share. This price is used in the Form 4 to quantify the tax-withholding disposition, reflecting the value applied for the shares delivered to cover the CFO’s tax obligations on vested restricted stock units.

How many Beauty Health (SKIN) shares does the CFO hold after this transaction?

After the tax-withholding transaction, CFO Michael Monahan directly holds 1,987,637 shares. This post-transaction balance indicates that the withholding represented a small portion of his overall position and that he continues to retain a large direct equity stake.

Does the Form 4 indicate that the Beauty Health (SKIN) CFO sold shares in the market?

The Form 4 states the transaction does not represent a sale. The 26,776 shares were withheld by the issuer solely to satisfy tax withholding requirements related to restricted stock unit vesting, not disposed of through an open-market or negotiated sale transaction.